201 related articles for article (PubMed ID: 12166605)
1. 1,5-anhydro-D-glucitol: a novel marker of glucose excursions.
Dworacka M; Winiarska H; Szymanska M; Kuczynski S; Szczawinska K; Wierusz-Wysocka B
Int J Clin Pract Suppl; 2002 Jul; (129):40-4. PubMed ID: 12166605
[TBL] [Abstract][Full Text] [Related]
2. The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients.
Dworacka M; Winiarska H
Dis Markers; 2005; 21(3):127-32. PubMed ID: 16276006
[TBL] [Abstract][Full Text] [Related]
3. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
4. Plasma anhydro-D-glucitol (1,5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes.
Dworacka M; Wender-Ozegowska E; Winiarska H; Borowska M; Zawiejska A; Pietryga M; Brazert J; Szczawinska K; Bobkiewicz-Kozłowska T
Diabet Med; 2006 Feb; 23(2):171-5. PubMed ID: 16433715
[TBL] [Abstract][Full Text] [Related]
5. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
[TBL] [Abstract][Full Text] [Related]
6. 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.
Kishimoto M; Yamasaki Y; Kubota M; Arai K; Morishima T; Kawamori R; Kamada T
Diabetes Care; 1995 Aug; 18(8):1156-9. PubMed ID: 7587851
[TBL] [Abstract][Full Text] [Related]
7. A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.
Wang Y; Zhang YL; Wang YP; Lei CH; Sun ZL
Diabetes Metab Res Rev; 2012 May; 28(4):357-62. PubMed ID: 22238204
[TBL] [Abstract][Full Text] [Related]
8. Ability of 1,5-Anhydro-d-glucitol Values to Predict Coronary Artery Disease in a Non-Diabetic Population.
Ikeda N; Hara H; Hiroi Y
Int Heart J; 2015; 56(6):587-91. PubMed ID: 26549287
[TBL] [Abstract][Full Text] [Related]
9. Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.
Dworacka M; Winiarska H; Borowska M; Abramczyk M; Bobkiewicz-Kozlowska T; Dworacki G
Circ J; 2007 Jun; 71(6):962-7. PubMed ID: 17526997
[TBL] [Abstract][Full Text] [Related]
10. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
Monnier L; Colette C
Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
[TBL] [Abstract][Full Text] [Related]
11. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
Monnier L; Colette C; Owens DR
Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415
[TBL] [Abstract][Full Text] [Related]
12. Association of reduced levels of serum 1,5-Anhydro-d-glucitol with carotid atherosclerosis in patients with type 2 diabetes.
Sato T; Kameyama T; Inoue H
J Diabetes Complications; 2014; 28(3):348-52. PubMed ID: 24560424
[TBL] [Abstract][Full Text] [Related]
13. Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
Paul SK; Holman RR
Diabet Med; 2017 Sep; 34(9):1284-1290. PubMed ID: 28477414
[TBL] [Abstract][Full Text] [Related]
14. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
Dungan KM; Buse JB; Largay J; Kelly MM; Button EA; Kato S; Wittlin S
Diabetes Care; 2006 Jun; 29(6):1214-9. PubMed ID: 16731998
[TBL] [Abstract][Full Text] [Related]
15. 1,5-Anhydro-D-glucitol predicts coronary artery disease prevalence and complexity.
Ikeda N; Hara H; Hiroi Y
J Cardiol; 2014 Oct; 64(4):297-301. PubMed ID: 24679905
[TBL] [Abstract][Full Text] [Related]
16. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating RANTES in type 2 diabetes.
Dworacka M; Krzyżagórska E; Iskakova S; Bekmukhambetov Y; Urazayev O; Dworacki G
Eur Cytokine Netw; 2014; 25(3):46-51. PubMed ID: 25373852
[TBL] [Abstract][Full Text] [Related]
18. Impact of serum 1,5-anhydro-D-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study.
Wada H; Dohi T; Miyauchi K; Takahashi N; Endo H; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
Cardiovasc Diabetol; 2019 Jun; 18(1):69. PubMed ID: 31159826
[TBL] [Abstract][Full Text] [Related]
19. 1,5-Anhydro-d-glucitol in vitreous humor and cerebrospinal fluid - A helpful tool for identification of diabetes and diabetic coma post mortem.
Sydow K; Kueting T; Musshoff F; Madea B; Hess C
Forensic Sci Int; 2018 Aug; 289():397-407. PubMed ID: 29966937
[TBL] [Abstract][Full Text] [Related]
20. Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes.
Ma C; Sheng J; Liu Z; Guo M
Sci Rep; 2017 Mar; 7():44291. PubMed ID: 28281675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
